Effector Therapeutics
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 (NCT04632381) | Effector Therapeutics | 2021-07-01 |
| Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies (NCT04092673) | Effector Therapeutics | 2019-10-25 |
| An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (NCT03690141) | Effector Therapeutics | 2018-11-27 |
| Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy (NCT03616834) | Effector Therapeutics | 2018-07-25 |
| A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer (NCT03258398) | Effector Therapeutics | 2017-09-18 |
Track Effector Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.